Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Osseointegration

Back to Topics
Contents
0%

Osseointegration

Comprehensive guide to osseointegration mechanisms, surface modifications, implant stability, and clinical applications in orthopaedic surgery

complete
Updated: 2025-12-25
High Yield Overview

OSSEOINTEGRATION

Direct Bone-Implant Contact | Surface-Dependent | Biomechanical Fixation | Time-Dependent Process

3-6 monthsPrimary integration period
60-90%Bone-implant contact in successful integration
50nmCritical gap for direct integration
20μmMaximum gap for successful osseointegration

STAGES OF OSSEOINTEGRATION

Primary Stability
PatternMechanical press-fit at surgery
TreatmentImmediate post-op
Secondary Stability
PatternBiological fixation via bone formation
Treatment3-6 months
Functional Adaptation
PatternBone remodeling to load
TreatmentOngoing

Critical Must-Knows

  • Osseointegration = direct structural and functional connection between bone and implant surface
  • Titanium is gold standard due to oxide layer and biocompatibility
  • Surface roughness (1-10 micrometers) enhances bone apposition and integration
  • Primary stability (press-fit) essential for successful secondary biological fixation
  • Micromotion greater than 150 micrometers inhibits osseointegration and promotes fibrous tissue

Examiner's Pearls

  • "
    Distance osteogenesis (bone grows from host bed) requires gap less than 500 micrometers
  • "
    Contact osteogenesis (bone forms on implant) requires rough surface and biocompatible material
  • "
    Porous coatings allow bone ingrowth (50-400 micrometer pores optimal)
  • "
    Hydroxyapatite coating accelerates early integration but may degrade over time

Critical Osseointegration Exam Points

Definition

Osseointegration is direct bone-to-implant contact without intervening fibrous tissue layer. First described by Brånemark in dental implants. Requires biocompatible material, stable fixation, and appropriate healing time.

Titanium Oxide Layer

Titanium spontaneously forms TiO2 layer (2-10 nm thick) that is highly biocompatible and osteoconductive. This passivation layer prevents corrosion and allows direct bone apposition without inflammatory response.

Primary vs Secondary Stability

Primary stability = mechanical press-fit at surgery. Secondary stability = biological fixation via bone formation (3-6 months). Loss of primary stability before secondary stability develops leads to implant failure.

Micromotion Threshold

Micromotion greater than 150 micrometers at bone-implant interface prevents osseointegration and promotes fibrous tissue formation. Absolute stability required during healing period.

At a Glance

Osseointegration is the direct structural and functional connection between living bone and implant surface without intervening fibrous tissue, first described by Brånemark. Titanium is the gold standard due to its biocompatible TiO₂ oxide layer (2-10 nm) that allows direct bone apposition. The process requires primary mechanical stability (press-fit) followed by secondary biological stability (bone formation over 3-6 months). Critical threshold: micromotion greater than 150 μm prevents osseointegration and promotes fibrous tissue formation. Surface roughness of 1-10 μm optimizes osteoblast adhesion; porous coatings (50-400 μm pores) allow bone ingrowth. Distance osteogenesis (bone grows from host bed) requires gaps less than 500 μm, while contact osteogenesis (bone forms on implant) requires rough, biocompatible surfaces.

Mnemonic

TITANIUMTITANIUM - Why Titanium Osseointegrates

T
TiO2 oxide layer
2-10 nm passivation layer, biocompatible and osteoconductive
I
Inert and biocompatible
Minimal inflammatory response, no cytotoxicity
T
Tough mechanical properties
High strength-to-weight ratio, fatigue resistant
A
Allows bone apposition
Surface chemistry permits direct bone contact
N
No fibrous tissue interposition
Direct bone-implant contact without soft tissue
I
Immune tolerance
Does not trigger foreign body rejection
U
Uniform integration
Predictable and reliable osseointegration
M
Modifiable surface
Can be roughened, coated, or treated for enhanced integration

Memory Hook:TITANIUM is the gold standard because of its oxide layer and biocompatibility

Mnemonic

STABLESTABLE - Requirements for Osseointegration

S
Surface biocompatible
Titanium or other osteoconductive material
T
Tight press-fit initially
Primary stability essential (less than 150 micrometer motion)
A
Appropriate gap distance
Less than 500 micrometers for distance osteogenesis
B
Bone quality adequate
Sufficient trabecular and cortical bone for fixation
L
Load control during healing
Protected weight-bearing for 6-12 weeks minimum
E
Environment optimized
No infection, adequate vascularity, good nutrition

Memory Hook:STABLE fixation both mechanically and biologically is required for osseointegration

Mnemonic

ROUGHROUGH - Surface Modifications

R
Ra 1-10 micrometers optimal
Moderate roughness enhances integration
O
Osteoblast adhesion enhanced
Rough surface improves cell attachment
U
Undercutting increases contact
Surface irregularities provide mechanical interlock
G
Greater surface area
Increased area for bone apposition
H
Hydroxyapatite coating option
HA accelerates early integration

Memory Hook:ROUGH surfaces (moderate roughness 1-10 micrometers) enhance osseointegration

Overview and Definition

Osseointegration is the direct structural and functional connection between ordered, living bone and the surface of a load-bearing implant without intervening fibrous tissue.

Historical context: First described by Per-Ingvar Brånemark in 1952 when he observed titanium chambers becoming permanently incorporated into rabbit bone. He coined the term "osseointegration" in 1981 and applied the principle to dental implants, revolutionizing implant dentistry and later orthopaedic surgery.

Why osseointegration matters clinically:

Implant Longevity

Successful osseointegration provides durable biological fixation for joint replacements, dental implants, and bone-anchored prostheses. Failure to osseointegrate leads to aseptic loosening and revision surgery.

Load Transfer

Direct bone-implant contact allows physiological load transfer without stress shielding or interface breakdown. Fibrous fixation creates pain and progressive loosening under cyclic loading.

Osseointegration vs Biointegration

Osseointegration specifically refers to bone-implant contact. Biointegration is broader term including soft tissue integration (e.g., tendon-bone, ligament-bone). In exams, use "osseointegration" for bone-implant interfaces and be specific about the tissue type involved.

Concepts and Mechanisms

Fundamental Principles of Osseointegration

Direct bone-implant contact without fibrous tissue interposition is the hallmark of successful osseointegration. This biological phenomenon requires specific conditions and materials to occur reliably.

Three key concepts:

1. Biocompatibility:

  • Titanium's spontaneous oxide layer (TiO2) is chemically inert
  • No inflammatory or foreign body response
  • Allows protein adsorption and cell adhesion
  • Other materials (tantalum, hydroxyapatite) also biocompatible

2. Mechanical stability:

  • Primary stability (press-fit at surgery) prevents early micromotion
  • Micromotion threshold: less than 150 micrometers allows osseointegration
  • Secondary stability (biological fixation) develops over 3-6 months
  • Load transfer through direct bone-implant contact

3. Biological healing:

  • Contact osteogenesis: bone forms directly ON implant surface
  • Distance osteogenesis: bone bridges gap FROM host bone
  • Timeline: woven bone (weeks 2-4), lamellar bone (months 3-6)
  • Surface roughness (1-10 micrometers) enhances osteoblast adhesion

Osseointegration vs Fibrous Fixation

Osseointegration (bone-implant contact) provides stable, load-bearing fixation for decades. Fibrous fixation (soft tissue interposition) is mechanically weak, painful under load, and leads to progressive loosening. The difference is determined by primary stability and micromotion control during healing.

Biological Mechanisms of Osseointegration

Osseointegration occurs through two primary mechanisms:

Contact Osteogenesis - Bone Forms ON Implant Surface

Mechanism:

  • Mesenchymal stem cells differentiate directly on implant surface
  • Osteoblasts deposit bone matrix directly onto implant
  • No intervening cartilage or fibrous tissue
  • Requires biocompatible surface chemistry

Requirements:

  • Biocompatible material (titanium, tantalum, hydroxyapatite)
  • Surface roughness (1-10 micrometers optimal)
  • Micromotion less than 150 micrometers
  • No bacterial contamination

Timeline:

  • Day 0-7: Hematoma formation, inflammatory phase
  • Week 1-2: Mesenchymal stem cell recruitment to surface
  • Week 2-4: Osteoblast differentiation, woven bone deposition
  • Week 4-12: Woven bone remodeling to lamellar bone
  • Month 3-6: Mature lamellar bone with direct implant contact

Surface Roughness Window

Moderate roughness (Ra 1-10 micrometers) is optimal. Smooth surfaces (less than 1 micrometer) have poor osteoblast attachment. Very rough surfaces (greater than 10 micrometers) trap bacteria and inflammatory cells, increasing infection risk.

Contact osteogenesis is the primary mechanism for cementless implants with rough surfaces.

Distance Osteogenesis - Bone Grows FROM Host Bed

Mechanism:

  • Bone formation begins at host bone surface
  • Osteoblasts migrate across gap toward implant
  • New bone bridges the gap between host and implant
  • Similar to fracture healing (gap healing)

Requirements:

  • Gap less than 500 micrometers (ideally less than 200 micrometers)
  • Stable fixation (no micromotion)
  • Adequate vascularity in gap region
  • Time for bone migration (slower than contact osteogenesis)

Timeline:

  • Week 0-2: Blood clot fills gap, angiogenesis begins
  • Week 2-4: Woven bone forms from host bed outward
  • Week 4-8: Bone bridges gap to reach implant surface
  • Week 8-16: Consolidation and remodeling
  • Month 4-12: Mature lamellar bone fills gap

Gap size critical:

  • Less than 50 micrometers: Direct apposition, optimal
  • 50-200 micrometers: Reliable osseointegration
  • 200-500 micrometers: Possible but delayed integration
  • Greater than 500 micrometers: Fibrous tissue interposition, integration fails

Gap Size Threshold

Gaps greater than 500 micrometers do not reliably osseointegrate. Fibrous tissue forms instead of bone, leading to unstable fixation and eventual loosening. Ensure tight press-fit (less than 200 micrometer gap) at surgery.

Distance osteogenesis occurs around smooth-surfaced implants and in small gaps around press-fit components.

Bone Remodeling and Functional Adaptation

After initial integration (3-6 months), ongoing remodeling occurs:

Wolff Law application:

  • Bone remodels according to mechanical stress
  • Well-loaded areas: bone density increases
  • Stress-shielded areas: bone resorption occurs
  • Load transfer pattern determines bone architecture

Remodeling timeline:

  • Months 6-12: Initial adaptation to loading
  • Years 1-5: Progressive remodeling, density equilibrium
  • Years 5+: Stable bone-implant interface (if loading appropriate)

Complications of maladaptation:

  • Stress shielding: Proximal bone loss around stiff femoral stems
  • Overload: Peri-implant fracture or bone resorption
  • Micromotion: Late loosening if fixation inadequate

Stress Shielding

Stiff implants (e.g., cobalt-chrome femoral stems) transfer load distally, shielding proximal bone from stress. This causes proximal bone resorption per Wolff law. Titanium stems (lower modulus) reduce stress shielding compared to cobalt-chrome.

Ongoing remodeling means osseointegration is not a static endpoint but a dynamic process throughout implant life.

Cellular and Molecular Events

Cell types involved:

Cell TypeTimingFunctionSignificance
PlateletsDay 0-1Release growth factors (PDGF, TGF-β)Initiate healing cascade
NeutrophilsDay 1-3Debris removal, inflammatory signalsAcute inflammation (normal)
MacrophagesDay 3-7Phagocytosis, release cytokinesTransition to repair phase
MSCsDay 7-14Differentiate to osteoblastsKey cells for bone formation
OsteoblastsDay 14+Deposit bone matrix on implantCreate osseointegration
OsteoclastsWeek 4+Remodel woven to lamellar boneMature bone formation

Growth factors and signaling:

  • BMP-2, BMP-7: Osteoblast differentiation
  • VEGF: Angiogenesis, essential for bone formation
  • PDGF, TGF-β: Mesenchymal stem cell recruitment
  • FGF: Osteoblast proliferation

Surface protein adsorption:

  • Fibronectin, vitronectin adsorb to titanium surface within minutes
  • These proteins provide attachment sites for osteoblasts
  • Integrin receptors on osteoblasts bind to surface proteins
  • Cell adhesion triggers osteogenic differentiation signals

Understanding cellular events helps optimize implant design and surgical technique.

Materials and Surface Modifications

Titanium and Titanium Alloys

Pure titanium (Grade 1-4):

  • Excellent biocompatibility
  • Spontaneous TiO2 layer (2-10 nm thick)
  • Moderate strength, good corrosion resistance
  • Used in dental implants, some bone screws

Titanium-6-Aluminum-4-Vanadium (Ti-6Al-4V):

  • Most common orthopaedic titanium alloy
  • Higher strength than pure titanium
  • Lower modulus than cobalt-chrome (110 vs 210 GPa)
  • Still forms protective TiO2 oxide layer
  • Used in femoral stems, acetabular cups, fracture fixation

Oxide layer properties:

  • Forms spontaneously in air/body fluids (milliseconds)
  • Self-healing if scratched
  • Prevents metal ion release
  • Negatively charged surface attracts proteins and cells

Titanium vs Cobalt-Chrome

Titanium (modulus 110 GPa) reduces stress shielding compared to cobalt-chrome (modulus 210 GPa) but is softer and more prone to scratching. Cobalt-chrome has better wear properties for bearing surfaces, titanium better for stems and fixation.

Titanium is the gold standard for osseointegration due to its oxide layer and biocompatibility.

Surface Roughness and Texture

Surface roughness measurement: Ra (average roughness)

Surface Roughness and Osseointegration

Surface TypeRa (micrometers)OsseointegrationClinical Use
Smooth/polishedLess than 0.5Poor (fibrous tissue)Cemented stems (smooth for cement interlock)
Minimally rough0.5-1.0ModerateSome grit-blasted implants
Moderately rough1.0-10Excellent (optimal)Cementless stems, acetabular cups
Very roughGreater than 10Good but infection riskSome older porous coatings

Methods to create roughness:

  1. Grit blasting: Alumina or titanium particles (50-200 micrometers) blasted at high pressure

    • Creates Ra 1-5 micrometers
    • Uniform roughness
    • May leave contaminants (clean thoroughly)
  2. Acid etching: HCl/H2SO4 removes surface material

    • Creates micropits (1-10 micrometers)
    • Very clean surface
    • Often combined with grit blasting
  3. Plasma spraying: Titanium particles melted and sprayed

    • Creates coating 50-200 micrometers thick
    • High roughness (Ra 5-20 micrometers)
    • Risk of coating delamination
  4. Anodization: Electrochemical oxidation

    • Creates TiO2 nanotubes (20-100 nm diameter)
    • Nanotexture enhances integration
    • Newer technology, promising results

Cleaning Critical

Surface contaminants from manufacturing (oils, particles) must be removed before implantation. Contamination inhibits osseointegration and increases infection risk. Ultrasonic cleaning and passivation standard.

Moderate roughness (Ra 1-10 micrometers) is optimal for osseointegration.

Porous Coatings for Bone Ingrowth

Porous coatings allow bone to grow INTO implant surface (not just onto it):

Optimal pore characteristics:

  • Pore size: 50-400 micrometers (100-200 optimal)
  • Porosity: 30-50% of coating volume
  • Interconnected pores required
  • Coating thickness: 500-1000 micrometers

Coating methods:

  1. Sintered beads: Titanium or cobalt-chrome beads sintered to surface

    • Bead size 200-400 micrometers
    • 30-40% porosity
    • Strong attachment, proven track record
    • Used in many acetabular cups and femoral stems
  2. Fiber metal: Titanium fiber mesh sintered to surface

    • Open structure, high porosity (40-50%)
    • Large contact area for bone ingrowth
    • Good fatigue resistance
  3. Trabecular metal (tantalum): Porous tantalum structure

    • 70-80% porosity, very bone-like
    • Excellent biocompatibility
    • Lower modulus than solid metal
    • Expensive, used in revision surgery

Advantages of porous coatings:

  • Greater bone-implant contact area
  • Mechanical interlock from ingrowth
  • Very stable long-term fixation

Disadvantages:

  • Requires longer immobilization (bone must grow into pores)
  • Difficult to remove if revision needed
  • Higher infection risk if bacteria colonize pores
  • More expensive manufacturing

Ingrowth vs Ongrowth

Bone ingrowth (porous coatings): bone grows INTO pores. Bone ongrowth (roughened surfaces): bone grows ONTO surface. Ingrowth provides stronger fixation but takes longer to establish.

Porous coatings provide excellent long-term fixation but require protected weight-bearing during ingrowth.

Hydroxyapatite (HA) Coating

Hydroxyapatite Ca10(PO4)6(OH)2 is the mineral phase of bone.

Application method: Plasma spraying

  • HA powder heated to 10,000-15,000°C
  • Sprayed onto titanium substrate
  • Creates coating 50-150 micrometers thick
  • Crystalline or amorphous structure depending on process

Advantages of HA coating:

  • Osteoconductive (bone forms readily on HA)
  • Accelerates early osseointegration (2-4 weeks faster than titanium alone)
  • Higher bone-implant contact area early (6-12 weeks)
  • May allow earlier weight-bearing

Disadvantages and concerns:

  • HA may resorb over time (5-10 years)
  • Coating delamination possible if poorly bonded
  • Increased risk of third-body wear if particles released
  • Long-term benefit unclear (some studies show no difference at 5+ years)

HA-Coated vs Uncoated Titanium

FeatureHA-Coated TitaniumUncoated Titanium
Early osseointegrationFaster (6-8 weeks)Slower (12-16 weeks)
Long-term fixationSimilarSimilar
Coating durabilityMay resorb over yearsNo coating to fail
Revision difficultyMore difficult if coatedStandard difficulty
CostHigherLower

HA Coating Controversy

HA coating accelerates early integration but long-term benefit is controversial. Some studies show coating resorption by 5-10 years. Use in revision surgery where rapid integration desired, but uncoated titanium adequate for primary surgery in most cases.

HA coating accelerates early integration but long-term advantage over uncoated titanium is uncertain.

Primary and Secondary Stability

Understanding stability transition is critical for successful osseointegration:

Implant Stability Over Time

SurgeryDay 0

Primary (mechanical) stability: Press-fit fixation, friction at bone-implant interface. Depends on implant geometry, bone quality, surgical technique. Must prevent micromotion greater than 150 micrometers.

Danger ZoneWeeks 0-6

Decreasing primary stability: Bone resorption at interface due to surgical trauma. Primary stability declines before secondary stability develops. Risk period for early loosening if inadequate initial fixation or excessive loading.

TransitionWeeks 6-12

Emerging secondary stability: Woven bone forms at interface, begins to provide biological fixation. Gradual increase in bone-implant contact. Stability minimum occurs around 6-8 weeks, then increases.

Biological FixationMonths 3-6

Secondary (biological) stability: Lamellar bone remodeling, mature osseointegration. Bone-implant contact 60-90%. Stable fixation can now tolerate full physiological loads.

Functional AdaptationYears 1+

Ongoing remodeling: Bone adapts to loading patterns per Wolff law. Density increases in loaded areas, decreases in shielded areas. Stable equilibrium if loading appropriate.

Stability Valley

Weeks 6-8 post-op are critical period when primary stability declining but secondary stability not yet established. This "stability valley" is when implants are most vulnerable to failure. Protected weight-bearing essential during this period.

Factors affecting primary stability:

Implant Factors

  • Geometry (tapered better than straight)
  • Diameter (larger = more contact)
  • Length (longer = more fixation area)
  • Thread design (for screws)
  • Surface coefficient of friction

Bone Factors

  • Bone density (cortical better than trabecular)
  • Bone quality (young better than osteoporotic)
  • Surgical technique (undersize vs oversize)
  • Anatomic location (metaphysis vs diaphysis)

Osteoporotic Bone

Poor bone quality (osteoporosis, revision surgery, elderly patients) reduces primary stability. Consider cement augmentation, longer stems, metaphyseal fixation, or protected weight-bearing for longer period (12 weeks vs 6 weeks).

Anatomy

Bone-Implant Interface Structure

Ultrastructure of osseointegrated interface:

From implant surface outward:

  1. Titanium oxide layer (TiO₂): 2-10 nm thick passivation layer
  2. Proteoglycan layer: 20-50 nm of adsorbed proteins (fibronectin, vitronectin)
  3. Mineralized bone: Direct apposition, no fibrous tissue
  4. Osteocyte network: Canaliculi connect to implant surface

Key observation: In successful osseointegration, bone mineral is in direct contact with the oxide layer at the molecular level

Zones of Bone at Interface

Histological zones around osseointegrated implant:

Zone 1 - Interface zone (0-50 μm):

  • Newly formed woven bone
  • High osteocyte density
  • Active remodeling

Zone 2 - Transition zone (50-500 μm):

  • Mixed woven and lamellar bone
  • Gradual maturation

Zone 3 - Host bone (greater than 500 μm):

  • Native cortical or cancellous bone
  • Normal architecture

Osseointegrated vs Fibrous Encapsulated Interface

FeatureOsseointegrationFibrous Encapsulation
Tissue at interfaceBone directly on implantFibrous tissue layer
Gap at interfaceLess than 50 nm50-500 μm fibrous membrane
Micromotion toleratedLess than 150 μmHigh micromotion present
Mechanical stabilityExcellentPoor (loose implant)
Clinical outcomeStable fixationImplant loosening
HistologyDirect bone contact (BIC%)Fibrous tissue, inflammation

What is Osseointegration?

Brånemark's definition: "Direct structural and functional connection between ordered, living bone and the surface of a load-carrying implant." At the ultrastructural level, this means bone mineral is in contact with the titanium oxide layer without intervening fibrous tissue. Clinically, this translates to stable, non-mobile fixation that can withstand functional loading.

Titanium Oxide Layer (TiO₂)

The foundation of biocompatibility:

Structure:

  • Thickness: 2-10 nm (spontaneously formed)
  • Composition: Amorphous or crystalline TiO₂
  • Regenerates within milliseconds if damaged (self-healing)

Biochemical properties:

  • Hydroxyl groups (-OH) on surface
  • Protein adsorption sites
  • Calcium phosphate precipitation sites
  • Low surface energy (low foreign body response)

Key point: The oxide layer, not the titanium metal, is what bone contacts

Protein Layer at Interface

Adsorbed protein layer mediates cell attachment:

Proteins adsorbed within seconds:

  • Fibronectin (cell adhesion)
  • Vitronectin (osteoblast binding)
  • Albumin (passivating protein)
  • Complement proteins

Cell-protein-implant interface:

  1. Proteins adsorb to TiO₂ surface
  2. Integrins (osteoblast receptors) bind to proteins
  3. Osteoblast adhesion and spreading
  4. Matrix deposition and mineralization

The "Vroman effect": protein composition changes over time

Bone-Implant Contact (BIC%) Measurement

Histomorphometric assessment of osseointegration:

Bone-implant contact (BIC%):

  • Definition: Percentage of implant surface in direct contact with bone
  • Successful integration: 60-90% BIC
  • Failure: Less than 30% BIC (fibrous tissue predominates)

Measurement methods:

  • Ground sections (implant left in situ)
  • Histology with image analysis software
  • Micro-CT for 3D assessment (research)

Factors affecting BIC:

  • Surface roughness (higher = better BIC)
  • Implant stability (primary stability essential)
  • Loading protocol (immediate vs delayed)
  • Patient factors (smoking, diabetes, medications)

Self-Healing Oxide Layer

If the titanium oxide layer is damaged (e.g., by scratching during surgery), it regenerates within milliseconds when exposed to oxygen or water. This "self-healing" property maintains biocompatibility even after surface damage. The oxide layer is not a coating that can be worn off - it is an intrinsic property of titanium in oxidizing environments.

Classification

Stages of Osseointegration

StageTimeframeProcessClinical Relevance
Primary stabilityDay 0 (surgery)Mechanical press-fitDetermined by bone quality, implant design, surgical technique
Healing phaseDays 1-14Hematoma, inflammation, angiogenesisProtected weight-bearing, avoid micromotion
Bone formationWeeks 2-6Osteoblast recruitment, woven boneGradual loading possible
Secondary stabilityMonths 1-3Bone remodeling, lamellar boneFull loading permitted
Functional adaptationMonths 3+Wolff's law remodeling to loadLong-term stability achieved

Classification by Bone Formation Type

Two mechanisms of bone apposition:

Distance osteogenesis:

  • Bone grows from host bone bed TOWARD implant
  • Requires gap less than 500 μm
  • Depends on osteoblasts migrating from host bone
  • Slower process (takes longer to bridge gap)

Contact osteogenesis:

  • Bone forms directly ON the implant surface
  • Osteogenic cells migrate to implant and deposit bone there
  • Requires rough, osteoconductive surface
  • Faster and more robust integration

Classification by Surface Type

Surface modification strategies:

Smooth (machined):

  • Ra less than 0.5 μm
  • Lowest bone-implant contact
  • Historical standard

Rough (textured):

  • Ra 1-10 μm (optimal range)
  • Grit-blasted, acid-etched, or sandblasted
  • Best osseointegration outcomes

Porous (ingrowth):

  • Pore size 50-400 μm
  • Allows bone to grow INTO surface
  • Sintered beads, plasma spray, 3D-printed

Distance vs Contact Osteogenesis

Distance osteogenesis = bone grows from host bed toward implant (requires small gap). Contact osteogenesis = bone forms directly on implant surface (requires rough, biocompatible surface). Contact osteogenesis is preferred as it is faster and results in better bone-implant contact. Most modern surface treatments aim to promote contact osteogenesis.

Surface Roughness Classification (Sa/Ra)

CategoryRa ValueExamplesClinical Outcome
SmoothLess than 0.5 μmMachined titaniumLowest BIC (30-40%), fibrous tissue risk
Minimally rough0.5-1.0 μmPolished, fine finishModerate integration
Moderately rough1.0-2.0 μmSLA, acid-etchedGood integration (50-70% BIC)
Rough2.0-10 μmGrit-blasted, TPSExcellent integration (60-90% BIC)
Very roughGreater than 10 μmPlasma spray, porousBone ingrowth, risk of ion release

Surface Coating Classifications

Coating strategies to enhance osseointegration:

Hydroxyapatite (HA) coating:

  • Composition: Ca₁₀(PO₄)₆(OH)₂
  • Thickness: 50-150 μm
  • Osteoconductive (accelerates early bone formation)
  • Concern: Coating dissolution, particle release

Titanium plasma spray (TPS):

  • Pure titanium particles sprayed onto substrate
  • Roughness: 20-50 μm
  • Good osseointegration, durable

Porous coatings:

  • Sintered beads, fiber mesh, 3D-printed trabeculae
  • Pore size: 50-400 μm optimal (allows bone ingrowth)
  • Mechanical interlock (not just surface apposition)

Modern Surface Technologies

Advanced surface modifications:

SLA (Sandblasted, Large-grit, Acid-etched):

  • Two-step process: grit-blasting then acid etching
  • Creates micro-roughness (1-2 μm) and nano-texture
  • Excellent clinical track record

Nanotechnology surfaces:

  • Nano-roughness (10-100 nm)
  • Increases protein adsorption
  • May accelerate early healing

Bioactive coatings:

  • Growth factors (BMP, PDGF) incorporated
  • Research stage, not widely used clinically
  • Regulatory challenges for biologics on implants

Albrektsson Criteria for Osseointegration

Clinical success criteria (modified from Albrektsson 1986):

Original criteria for dental implants (adapted to orthopaedics):

  1. Individual implant immobility when tested clinically
  2. No peri-implant radiolucency on radiographs
  3. Mean vertical bone loss less than 0.2 mm annually after first year
  4. No persistent pain, infection, or neuropathy
  5. Cumulative success rate of 85% at 5 years, 80% at 10 years

For orthopaedic implants:

  • Stable implant at revision (requires extraction tools)
  • Bone-implant contact greater than 50% on histology
  • Absence of progressive radiolucent lines on serial X-rays

Pore Size for Bone Ingrowth

Optimal pore size for bone ingrowth: 50-400 μm. Pores less than 50 μm do not allow vascular ingrowth and bone penetration. Pores greater than 400 μm may be too large for trabeculae to bridge and may weaken the coating. This is a classic viva question - know the numbers!

Clinical Applications in Orthopaedics

Cementless Joint Replacement

Total hip arthroplasty:

  • Femoral stems: Proximal porous coating or full coating
  • Acetabular cups: Hemispherical, press-fit, porous coated
  • Success rate greater than 95% at 10 years with modern designs
  • Osseointegration evident by 3-6 months on radiographs

Radiographic signs of osseointegration:

  • No progressive radiolucent lines
  • Bone densification adjacent to implant (spot welds)
  • Endosteal bone formation (calcar remodeling in hip)
  • No subsidence or migration after initial settling

Total knee arthroplasty:

  • Cementless components less common than hip (cemented standard)
  • Porous-coated tibial baseplates and femoral components available
  • Younger patients (less than 55 years) may benefit from cementless fixation
  • Requires good bone quality and precise surgical technique

Shoulder arthroplasty:

  • Glenoid component: Controversial (cemented vs cementless)
  • Humeral stem: Cementless common, press-fit metaphyseal fixation
  • Reverse shoulder: Glenoid baseplate osseointegration critical for longevity

Cemented vs Cementless Indications

Cementless preferred in younger patients (less than 60-65 years) with good bone quality - allows bone ingrowth, no cement mantle to fail. Cemented preferred in elderly, osteoporotic bone, or when immediate fixation required (no 6-12 week protected weight-bearing).

Spinal Fusion Implants

Pedicle screws:

  • Titanium alloy standard (osseointegrates to vertebral bone)
  • Immediate mechanical fixation, biological fixation develops over months
  • Osseointegration improves pullout strength over time
  • Fusion mass incorporation depends on graft and biologics

Interbody cages:

  • Titanium or PEEK (polyetheretherketone)
  • PEEK does NOT osseointegrate (bioinert, not bioactive)
  • Titanium cages osseointegrate at endplate interface
  • Bone graft within cage provides fusion, cage provides structure

Cervical disc replacement:

  • Articulating implants with bone-contacting surfaces
  • Some designs rely on osseointegration for fixation (no screws)
  • Surface coating (plasma spray, HA) enhances integration
  • Concerns about long-term loosening and wear

PEEK Limitation

PEEK is radiolucent (helps visualize fusion on imaging) but does NOT osseointegrate. Use titanium if osseointegration desired for fixation. PEEK relies on friction and endplate contact, not biological fixation.

Dental Implants - Where It All Started

Dental implant osseointegration:

  • Brånemark original application (1960s-1980s)
  • Titanium root-form implants placed in mandible/maxilla
  • 6-month healing before loading (mandible 3 months, maxilla 6 months)
  • Success rate greater than 95% at 10 years

Factors affecting dental osseointegration:

  • Bone density (mandible better than maxilla)
  • Implant diameter and length (larger = better survival)
  • Loading protocol (immediate vs delayed loading)
  • Smoking (reduces success rate 10-20%)
  • Diabetes (poor glycemic control impairs integration)

Maxillofacial reconstruction:

  • Orbital floor implants (titanium mesh)
  • Mandibular reconstruction plates
  • Bone-anchored hearing aids (temporal bone integration)

The principles established in dental implantology directly apply to orthopaedic applications.

Bone-Anchored Prostheses

Osseointegrated prosthetic limbs:

  • Titanium implant placed into residual bone (femur, tibia, humerus)
  • External abutment connects to prosthetic limb
  • Eliminates socket issues (skin breakdown, suspension problems)
  • Improved proprioception and function vs socket prosthesis

Two-stage surgical technique:

  • Stage 1: Implant placement, osseointegration period (6 months)
  • Stage 2: Skin-penetrating abutment attached, gradual loading
  • Critical to prevent infection at skin-implant interface

Tumor reconstruction:

  • Megaprostheses after tumor resection
  • Porous-coated segments for host bone fixation
  • Osseointegration provides long-term stable fixation
  • Alternative to allograft-prosthetic composites

Transcutaneous Osseointegration Challenges

Skin-penetrating abutments (dental, bone-anchored limbs) create infection risk where skin meets implant. Meticulous hygiene, antibacterial coatings, and close surveillance essential. Infection rate 10-30% in early experience, improving with technique refinement.

Factors Affecting Osseointegration Success

Factors Influencing Osseointegration

FactorFavorableUnfavorableClinical Strategy
Bone qualityYoung, dense, healthy boneOsteoporotic, irradiated boneAugment poor bone with cement or biologics
Primary stabilityPress-fit, less than 150 micrometer motionLoose fit, excessive motionUndersize preparation, larger implant, screw fixation
Gap distanceLess than 200 micrometersGreater than 500 micrometersLine-to-line or undersize by 1mm maximum
LoadingProtected 6-12 weeks, gradual increaseImmediate full weight-bearingCrutches, walker, graduated progression
SurfaceRough (Ra 1-10 micrometers), cleanSmooth, contaminatedGrit-blast and acid-etch, ultrasonic clean
VascularityGood blood supply, youngAvascular, smoker, diabeticOptimize medical conditions, smoking cessation
InfectionSterile technique, prophylaxisBacterial contaminationAntibiotics, debridement if infected
Patient factorsHealthy, compliantDiabetes, smoking, steroidsMedical optimization, patient education

Critical thresholds to remember:

Risk Factors for Failure

High-risk scenarios for osseointegration failure:

  • Revision surgery (poor bone stock, scar tissue)
  • Osteoporotic bone (reduced primary stability)
  • Smoking (impairs angiogenesis and bone formation)
  • Diabetes (poor glycemic control reduces healing)
  • Infection (promotes fibrous tissue, prevents bone apposition)
  • Excessive early loading (micromotion greater than 150 micrometers prevents integration)

Investigations

Radiographic Assessment

Plain radiographs:

Signs of successful osseointegration:

  • Stable implant position on serial X-rays
  • No progressive radiolucent lines at interface
  • Trabecular bone incorporation into porous surface
  • No subsidence or migration

Signs of failure/loosening:

  • Progressive radiolucent lines (greater than 2mm = definite loosening)
  • Implant migration or subsidence
  • Reactive sclerosis (stress shielding pattern)
  • Component rotation or angular change

Clinical Assessment

Exam findings of osseointegration status:

Well-osseointegrated implant:

  • Pain-free function
  • No start-up pain (pain on first few steps)
  • Stable on clinical exam
  • Normal gait pattern

Loose implant:

  • Activity-related pain (especially with loading)
  • Start-up pain (classic sign of femoral loosening)
  • Thigh pain (femoral stem loosening)
  • May be stable initially (fibrous fixation) but progressive

Radiolucent Line Interpretation

WidthZones InvolvedProgressionInterpretation
Less than 1mmPartial (1-2 zones)StableLikely normal healing or fibrous tissue at interface
1-2mmMultiple zonesStableFibrous fixation, monitor closely
Greater than 2mmComplete (all zones)ProgressiveDefinite loosening, failure of osseointegration
Any widthAnyIncreasing over timeActive loosening process, intervention required

Radiolucent Lines and Osseointegration

Radiolucent lines greater than 2mm or progressive radiolucent lines indicate failure of osseointegration. In a well-osseointegrated implant, there should be no radiolucent line at the bone-implant interface - bone is in direct contact with the porous surface. Partial radiolucent lines less than 1mm may represent normal trabecular remodeling, but complete radiolucent lines indicate fibrous encapsulation rather than osseointegration.

Advanced Imaging Modalities

CT scan:

  • Better visualization of bone-implant interface
  • Metal artifact reduction sequences (MARS)
  • Can detect early osteolysis not visible on X-ray
  • Quantify bone loss around implant

MRI (metal artifact reduction):

  • MAVRIC-SL, SEMAC sequences reduce artifact
  • Useful for soft tissue assessment around implant
  • Can detect periprosthetic infection (fluid, edema)
  • Limited for direct bone-implant interface visualization

Nuclear medicine:

  • Triple-phase bone scan (infection vs loosening)
  • Labeled white cell scan (infection)
  • PET-CT (emerging for infection diagnosis)

Research and Laboratory Methods

Histomorphometry (gold standard for research):

  • Bone-implant contact percentage (BIC%)
  • Bone area fraction occupancy (BAFO)
  • Requires implant retrieval or animal studies
  • Ground sections (implant in situ)

Micro-CT:

  • 3D assessment of bone around implant
  • Non-destructive (for retrieved specimens)
  • Quantify peri-implant bone volume
  • Research applications

Biomechanical testing:

  • Push-out or pull-out testing (shear strength)
  • Measures force required to dislodge implant
  • Correlates with degree of osseointegration

Gruen Zones and DeLee-Charnley Zones

Standardized zone systems for reporting radiolucent lines:

Gruen zones (femoral stem - THA):

  • 7 zones on AP view, 7 zones on lateral view
  • Zone 1 (greater trochanter) to Zone 7 (calcar)
  • Report presence, width, and progression of lucencies in each zone
  • Complete involvement of all zones = definite loosening

DeLee-Charnley zones (acetabular cup):

  • 3 zones on AP radiograph
  • Zone 1 (superolateral), Zone 2 (superior), Zone 3 (inferomedial)
  • Progressive lucencies in all 3 zones = cup loosening

Knee zones:

  • 7 zones for tibial component, 7 for femoral component
  • Report by zone for systematic documentation

Gruen Zones - Know the Numbers

Gruen zones are essential for systematic reporting of radiolucent lines around femoral stems. There are 7 zones on AP (Zone 1 = greater trochanter, Zone 7 = calcar) and 7 on lateral. For acetabular components, use DeLee-Charnley zones (3 zones). Examiners expect you to describe radiolucent lines by zone, width, and progression.

Management

📊 Management Algorithm
Management algorithm for Osseointegration
Click to expand
Management algorithm for OsseointegrationCredit: OrthoVellum

Optimizing Primary Stability

Surgical factors for successful osseointegration:

Implant selection:

  • Size appropriately (tight press-fit)
  • Surface: rough/porous for bone ingrowth
  • Material: titanium or Ti-6Al-4V alloy

Surgical technique:

  • Accurate reaming and broaching
  • Avoid thermal necrosis (cool irrigation)
  • Achieve press-fit (slightly undersized cavity)
  • Handle implant carefully (avoid scratching surface)

Intraoperative assessment:

  • Confirm stability before closure
  • Assess bone quality (adjust technique if osteoporotic)

Loading Protocol

Weight-bearing guidelines post-cementless THA:

Immediate full weight-bearing:

  • Modern cementless THA with good press-fit
  • Excellent bone quality
  • Standard approach (no osteotomies)

Protected weight-bearing (6-12 weeks):

  • Suboptimal primary stability
  • Osteoporotic bone
  • Revision surgery with bone grafting
  • Complex acetabular reconstruction

Delayed loading (dental/maxillofacial):

  • Traditional: 3-6 months before loading
  • Modern protocols allow earlier loading with good primary stability

Factors Affecting Osseointegration

FactorOptimization StrategyImpact on Success
Primary stabilityPress-fit, appropriate sizingEssential - without it, integration fails
Surface roughnessRa 1-10 μm, porous coatingHigher roughness improves BIC
MicromotionLimit to less than 150 μmExcessive motion = fibrous tissue
Gap distanceLess than 500 μm bone-implant gapLarge gaps delay/prevent integration
Bone qualityAddress osteoporosis if presentPoor bone = poor primary stability
Loading timingProtected WB until secondary stabilityEarly overload disrupts healing

Micromotion Threshold

Micromotion greater than 150 μm at the bone-implant interface prevents osseointegration and promotes fibrous encapsulation instead. This is why primary mechanical stability (press-fit) is essential - it limits micromotion during the healing period until secondary biological stability develops. Modern cementless implants can often tolerate immediate full weight-bearing because the press-fit achieves stability below the 150 μm threshold.

Patient Optimization

Modifiable risk factors:

Smoking:

  • 10-20% reduction in osseointegration success
  • Impairs angiogenesis and osteoblast function
  • Recommend cessation 4-6 weeks before surgery

Diabetes:

  • HbA1c greater than 8% associated with poorer outcomes
  • Optimize glycemic control preoperatively
  • Target HbA1c less than 7.5% if possible

Osteoporosis:

  • Reduced primary stability in osteoporotic bone
  • Consider bisphosphonates (do not impair integration)
  • May need longer protected weight-bearing

Medications:

  • NSAIDs: theoretical concern, short-term use likely acceptable
  • Corticosteroids: may impair bone healing
  • Bisphosphonates: do NOT impair osseointegration

Enhancing Osseointegration

Strategies to accelerate/improve integration:

Surface modifications:

  • Hydroxyapatite coating (accelerates early integration)
  • SLA surfaces (excellent clinical outcomes)
  • Nanotechnology surfaces (research stage)

Biologic enhancement:

  • Bone marrow aspirate (autologous cells)
  • Growth factors (BMP - not routinely used on implants)
  • Platelet-rich plasma (limited evidence for implants)

Pharmaceutical:

  • Bisphosphonates: do NOT impair, may enhance integration
  • PTH analogs (teriparatide): may enhance bone formation
  • Vitamin D optimization: address deficiency

When to Consider Cemented Fixation

Cementless osseointegration may not be appropriate when:

  • Severe osteoporosis (cannot achieve primary stability)
  • Elderly patients with limited life expectancy
  • Revision surgery with massive bone loss
  • Patient cannot comply with weight-bearing restrictions

In these cases, cemented fixation may provide more reliable immediate stability without relying on osseointegration.

NSAIDs and Osseointegration

The evidence on NSAIDs and osseointegration is nuanced. Animal studies suggest NSAIDs may impair bone formation around implants. However, clinical studies have not consistently shown worse outcomes. Most surgeons avoid prolonged NSAID use in the early postoperative period (6-12 weeks) as a precaution, but short-term use is likely acceptable. This is a common viva question where examiners want to see you acknowledge the controversy.

Surgical Technique

Principles for Achieving Osseointegration

Intraoperative goals:

1. Primary stability:

  • Tight press-fit (0.5-1mm undersizing)
  • Axial and rotational stability
  • No visible toggling of implant

2. Maximize bone-implant contact:

  • Accurate reaming/broaching
  • Minimal gap between bone and implant
  • Avoid excessive bone removal

3. Protect the interface:

  • Avoid thermal injury (cool irrigation)
  • Handle implant carefully (don't scratch surface)
  • Avoid contamination of porous surface

Steps for Cementless Femoral Stem

THA femoral stem insertion technique:

  • Start with smallest broach

  • Progress by 1-2 sizes until axial/rotational stability

  • Confirm leg length and offset

  • Assess stability through range of motion

  • Insert implant with axial impaction

  • Confirm stability (should require extraction instrument)

  • Implant should not move with manipulation

  • If unstable, upsize or consider cement

Technical Factors Affecting Osseointegration

FactorOptimal TechniqueConsequence of Error
Press-fit0.5-1mm undersizing of cavityToo loose = micromotion, failure
Thermal injuryCool irrigation during reamingBone necrosis, fibrous tissue
Implant handlingHandle by non-porous areas onlyScratching/contamination impairs integration
Bone preparationPreserve cancellous bone if possibleExcessive reaming = poor press-fit
Implant positionCorrect alignment and depthMalalignment increases stress, loosening

Press-Fit Sizing

Press-fit is achieved by undersizing the prepared cavity by 0.5-1mm relative to the implant size. This creates an interference fit where the bone is slightly compressed around the implant. Too tight risks fracture; too loose results in micromotion and failure of osseointegration. The final broach should feel stable with no toggle - if not, upsize.

Acetabular Cup Technique

Cementless acetabular component insertion:

Reaming:

  • Sequential hemispheric reamers
  • Ream to bleeding subchondral bone
  • Final reamer 1-2mm undersized to cup

Cup insertion:

  • Impact into prepared acetabulum
  • Target 40-45° inclination, 15-25° anteversion
  • Confirm stability (should require extractor)

Screw fixation (optional):

  • Provides additional primary stability
  • Place in safe zones (posterosuperior quadrant)
  • May not be required with good press-fit

Avoiding Thermal Necrosis

Bone necrosis from reaming heat:

Mechanism:

  • Friction from reaming generates heat
  • Temperature greater than 47°C for 1 minute causes osteocyte death
  • Dead bone cannot integrate, forms fibrous tissue

Prevention:

  • Cool saline irrigation during reaming
  • Sharp instruments (replace dull reamers)
  • Intermittent technique (pause to cool)
  • Avoid excessive force/speed

High-risk situations:

  • Dense sclerotic bone (revision surgery)
  • Power reaming without irrigation
  • Prolonged reaming with dull instruments

Handling Porous/Coated Implants

Protecting the surface during surgery:

DO:

  • Handle implant by smooth, non-porous areas
  • Use dedicated inserters designed for that implant
  • Keep implant in protective packaging until use
  • Insert carefully with controlled impaction

DON'T:

  • Touch porous surface with gloves or instruments
  • Allow implant to contact surgical drapes/gowns
  • Use metal instruments on porous surface
  • Drop or scratch the implant

Why it matters:

  • Contamination (fibers, debris) impairs bone contact
  • Scratching can damage oxide layer or coating
  • Surface damage reduces osseointegration potential

Temperature Threshold for Bone Necrosis

Bone temperatures greater than 47°C for more than 1 minute cause osteocyte death. This is why cool irrigation during reaming is essential. Dead bone at the implant interface cannot participate in osseointegration - it will be replaced by fibrous tissue, leading to implant loosening. This is a common cause of "unexplained" early loosening.

Complications

Failure of Osseointegration

Primary failure modes:

  • Aseptic loosening: Most common - fibrous encapsulation instead of bone integration
  • Periprosthetic infection: Bacteria prevent osseointegration, promote fibrous tissue
  • Periprosthetic fracture: Disrupts bone-implant interface
  • Stress shielding: Bone resorption from unloading (proximal femur in THA)

Key point: Any of these can occur early (failure to integrate) or late (loss of established integration)

Aseptic Loosening

The most common cause of THA/TKA revision:

Mechanisms:

  • Failure of primary stability (micromotion)
  • Fibrous encapsulation instead of bone formation
  • Progressive osteolysis from wear debris
  • Stress shielding and bone resorption

Clinical presentation:

  • Pain with activity (especially loading)
  • Start-up pain (classic for femoral stem)
  • Progressive symptoms over months-years

Radiographic signs:

  • Progressive radiolucent lines
  • Implant migration or subsidence
  • Osteolysis (scalloped lesions)

Stress Shielding

Bone resorption from altered loading:

Mechanism:

  • Stiff implant shields bone from normal stress
  • Bone resorbs per Wolff's law (use it or lose it)
  • Proximal femur most affected in THA

Severity (Engh classification):

  • Grade 1: Minimal (cortical thinning only)
  • Grade 2: Moderate (calcar rounding, cortical thinning)
  • Grade 3: Severe (absent calcar, marked thinning)

Prevention:

  • Shorter stems (preserves proximal loading)
  • Tapered stems (less distal fixation)
  • Lower modulus materials (titanium over CoCr)

Early vs Late Failure of Osseointegration

FeatureEarly Failure (less than 2 years)Late Failure (greater than 2 years)
CauseFailed primary stability, infectionOsteolysis, stress shielding, late infection
PresentationPersistent pain from surgeryNew onset pain after pain-free interval
HistologyFibrous tissue at interfaceOsteolysis, granuloma, bone resorption
X-rayEarly radiolucent lines, migrationProgressive osteolysis, stress shielding
ManagementRevision with optimized fixationRevision +/- bone grafting, address osteolysis

Osteolysis from Wear Debris

Wear debris (polyethylene, metal, ceramic) triggers a macrophage inflammatory response at the bone-implant interface. This releases osteoclast-activating cytokines (IL-1, IL-6, TNF-α), leading to bone resorption around the implant. This is why reducing wear (XLPE, ceramic bearings) is critical for long-term implant survival.

Periprosthetic Infection

Infection prevents and destroys osseointegration:

Mechanism:

  • Bacterial biofilm on implant surface
  • Inflammatory response destroys bone
  • Cannot achieve direct bone-implant contact

Risk factors:

  • Diabetes, smoking, obesity
  • Immunosuppression
  • Prolonged operative time
  • Prior surgery at site

Treatment:

  • Often requires implant removal
  • Staged revision (spacer, then reimplantation)
  • Cannot achieve osseointegration until infection cleared

Periprosthetic Fracture

Disrupts osseointegrated interface:

Classification (Vancouver for THA):

  • Type A: Trochanteric (A-G, A-L)
  • Type B: Around/below stem (B1, B2, B3)
  • Type C: Well distal to stem

B2 fractures (loose stem):

  • Fracture plus loss of osseointegration
  • Requires revision of loose stem
  • Challenging to achieve new integration

B1 fractures (well-fixed stem):

  • Fracture with intact osseointegration
  • ORIF if stable stem preserved
  • Integration maintained

Hydroxyapatite Coating Complications

Specific complications of HA-coated implants:

Coating delamination:

  • HA layer separates from metal substrate
  • Releases HA particles into joint
  • Can cause third-body wear, osteolysis
  • More common with thick coatings (greater than 100 μm)

Coating dissolution:

  • HA is bioabsorbable over time
  • May lose benefits of coating long-term
  • Crystalline HA more stable than amorphous

Clinical relevance:

  • HA coating accelerates early integration
  • Long-term benefit debated vs. porous titanium alone
  • Modern thin coatings (50-75 μm) have fewer issues

Stress Shielding Prevention

Stress shielding is worse with stiff, fully coated stems. Prevention strategies: (1) Use tapered, proximally coated stems that transfer load proximally; (2) Choose titanium over cobalt-chrome (lower modulus, more load to bone); (3) Consider shorter stems in appropriate patients. Once established, stress shielding is irreversible but often not clinically significant if implant remains well-fixed.

Postoperative Care

Weight-Bearing Protocol

Protecting osseointegration during healing:

Immediate weight-bearing (modern standard):

  • Most cementless THA with good press-fit
  • Evidence supports early mobilization
  • Limits micromotion if press-fit adequate

Protected weight-bearing (6-12 weeks):

  • Suboptimal primary stability
  • Complex reconstruction
  • Bone grafting around implant
  • Revision surgery

Progression:

  • Week 0-6: Per surgeon protocol
  • Week 6-12: Progress as tolerated
  • Month 3+: Full activities usually permitted

Follow-up Schedule

Monitoring osseointegration:

Early follow-up:

  • 2 weeks: Wound check
  • 6 weeks: Clinical review, X-ray
  • 3 months: Functional assessment

Annual surveillance:

  • Clinical exam: Pain, function, stability
  • X-ray: Radiolucent lines, osteolysis, position
  • Compare to baseline and prior films

Red flags requiring early review:

  • New onset pain after pain-free interval
  • Start-up pain or thigh pain
  • Signs of infection

Weight-Bearing Guidelines by Scenario

ScenarioWeight-BearingRationale
Standard cementless THA (good press-fit)Full WB immediatelyPrimary stability achieved, accelerates recovery
Osteoporotic bonePWB 6-12 weeksReduced primary stability, higher micromotion risk
Revision with bone graftingPWB 6-12 weeksAllow graft incorporation and integration
Acetabular reconstructionPWB 6-12 weeksProtect reconstruction until healed
Bone-anchored prosthesisGradual loading over monthsSkin-implant interface needs protection

Early Weight-Bearing is Safe

Modern evidence supports immediate full weight-bearing after cementless THA with adequate press-fit. Early studies recommended protected weight-bearing, but this was based on cemented implants. With modern porous-coated implants achieving good primary stability, early loading actually stimulates bone formation (Wolff's law) without compromising osseointegration. However, if press-fit is suboptimal, protected weight-bearing remains appropriate.

Medication Considerations

Drugs affecting osseointegration:

Avoid if possible (first 6-12 weeks):

  • NSAIDs: Theoretical concern, avoid prolonged use
  • Corticosteroids: Impair bone healing
  • Chemotherapy: Reduces bone formation

Do NOT need to stop:

  • Bisphosphonates: Do NOT impair osseointegration
  • Calcium/Vitamin D: Continue supplementation
  • Anticoagulation: Use per VTE protocol

Consider:

  • Optimize Vitamin D status (address deficiency)
  • Teriparatide: May enhance bone formation (off-label)

Radiographic Monitoring

What to look for on follow-up X-rays:

Signs of successful osseointegration:

  • Stable implant position over time
  • No radiolucent lines
  • Trabecular bone incorporation
  • No subsidence or migration

Signs of concern:

  • New or progressive radiolucent lines
  • Implant migration (compare to baseline)
  • Periprosthetic osteolysis
  • Stress shielding (proximal bone loss)

Baseline X-rays essential:

  • Obtain immediate postop or 6-week films
  • All future comparisons made to baseline

Activity Recommendations

Long-term activity after osseointegrated implant:

Generally permitted:

  • Walking (unlimited)
  • Swimming, cycling, golf
  • Low-impact activities
  • Return to sedentary work (2-6 weeks)
  • Return to physical work (3-6 months)

Caution advised:

  • Running, jumping (high impact)
  • Contact sports (fracture risk)
  • Heavy lifting (limit to functional needs)

Evidence:

  • Activity level does not clearly affect long-term survival
  • Higher activity may increase wear (less relevant with XLPE)
  • Patient satisfaction often higher with fewer restrictions

Thigh Pain After Cementless THA

Thigh pain after cementless THA is common in the first 12-18 months and often represents bone remodeling around the implant. It is more common with stiff, fully coated stems that engage the diaphysis. Most cases resolve spontaneously. However, progressive thigh pain with start-up symptoms or new radiolucent lines indicates failing osseointegration and requires closer monitoring.

Outcomes

Cementless THA Outcomes

Long-term results with osseointegrated implants:

Survival rates (AOANJRR 2023):

  • 10 years: 95-97%
  • 15 years: 92-95%
  • 20 years: 85-90%

Key findings:

  • Equivalent or superior to cemented in younger patients
  • Revision for aseptic loosening less than 5% at 15 years
  • XLPE has dramatically reduced wear-related failure

Factors predicting good outcome:

  • Good primary stability at surgery
  • Porous-coated titanium surface
  • Adequate liner thickness (XLPE)

Cementless TKA Outcomes

Cementless knee arthroplasty:

Survival rates:

  • 10 years: 95-96%
  • 15 years: 90-94%

Comparison to cemented:

  • Early studies showed higher loosening with cementless
  • Modern designs with trabecular metal show equivalent outcomes
  • AOANJRR: cemented slightly better at 15 years

Current recommendation:

  • Cemented remains gold standard for TKA
  • Cementless used selectively (younger patients, metaphyseal fixation)

Osseointegration Success by Application

ApplicationSuccess RateTime to IntegrationKey Factors
Cementless THA (stem)Over 95% at 15 years3-6 monthsSurface, press-fit, bone quality
Cementless THA (cup)Over 95% at 15 years3-6 monthsPress-fit, screw augmentation
Cementless TKA90-94% at 15 years3-6 monthsLess proven than cemented
Dental implants90-95% at 10 years3-6 monthsBone density, smoking, diabetes
Bone-anchored prosthesis90-95%6-12 monthsStaged protocol, skin care

Cementless vs Cemented - Current Evidence

For THA, cementless fixation is now standard in most patients under 70 years, with equivalent or superior long-term outcomes to cemented. For TKA, cemented fixation remains the gold standard with slightly better registry outcomes, though modern cementless designs are closing the gap. The choice depends on patient age, bone quality, and surgeon experience.

Retrieval Analysis Data

What we learn from retrieved implants:

Bone-implant contact (BIC%) in retrievals:

  • Well-fixed stems: 60-90% BIC
  • Loose stems: less than 30% BIC (fibrous tissue)
  • HA-coated: Higher early BIC, similar long-term

Factors associated with good BIC:

  • Rough/porous surface
  • Adequate primary stability
  • No infection

Histological findings:

  • Direct bone contact without fibrous layer
  • Lamellar bone adapted to loading
  • Osteocyte canaliculi extending to implant

Registry Outcome Data

AOANJRR (Australia) 2023:

Cementless vs cemented THA:

  • Cementless: 4.5% revision at 15 years
  • Cemented: 5.2% revision at 15 years
  • Hybrid: 4.8% revision at 15 years

Age-dependent differences:

  • Under 55: Cementless clearly superior
  • 55-75: Both excellent, cementless slightly better
  • Over 75: Cemented may be preferred (bone quality)

TKA:

  • Cemented: 5.8% revision at 15 years
  • Cementless: 6.9% revision at 15 years
  • Cemented remains preferred for TKA

Bone-Anchored Prosthesis Outcomes

Osseointegrated prosthetic limbs:

Transfemoral amputation:

  • Implant survival: 90-95% at 5 years
  • Infection rate: 10-20% (skin-implant interface)
  • Mechanical complications: 5-10%
  • Patient satisfaction: High (better than socket)

Functional outcomes:

  • Improved walking ability vs socket prosthesis
  • Enhanced proprioception (osseoperception)
  • Reduced skin problems (no socket)
  • Faster donning/doffing

Limitations:

  • Requires staged surgery (6-12 months)
  • Ongoing risk of infection at abutment
  • Limited to high-volume centers
  • Careful patient selection required

Age and Fixation Choice

Age-dependent fixation recommendations (general guidance):

  • Under 65: Cementless preferred (excellent long-term outcomes)
  • 65-75: Either option acceptable, surgeon/patient preference
  • Over 75: Cemented often preferred, especially if osteoporotic
  • Femoral neck fracture over 70: Cemented has lower fracture and mortality risk

These are general guidelines - individual patient factors (bone quality, expected activity, life expectancy) should guide decision-making.

Evidence Base

Brånemark Osseointegration - Original Description

5
Brånemark PI, et al. • Scand J Plast Reconstr Surg (1969)
Key Findings:
  • Titanium optical chambers implanted in rabbit bone became permanently fixed
  • Direct bone-to-titanium contact observed histologically without fibrous tissue layer
  • Coined term 'osseointegration' to describe this phenomenon
  • Established foundation for modern dental and orthopaedic implants
Clinical Implication: Seminal work demonstrating that titanium can achieve direct bone contact, revolutionizing implant design and clinical practice.

Surface Roughness and Osseointegration

3
Wennerberg A, Albrektsson T • Clin Oral Implants Res (2009)
Key Findings:
  • Moderate surface roughness (Ra 1-10 micrometers) optimal for osseointegration
  • Smooth surfaces (Ra less than 0.5 micrometers) show poor bone apposition
  • Very rough surfaces (Ra greater than 10 micrometers) increase infection risk
  • Surface topography more important than chemistry for titanium implants
Clinical Implication: Defines optimal surface roughness range for cementless implants. Modern implants designed with Ra 1-10 micrometers via grit-blasting or acid-etching.

Micromotion and Osseointegration Failure

4
Pilliar RM, et al. • Clin Orthop Relat Res (1986)
Key Findings:
  • Micromotion greater than 150 micrometers prevents osseointegration
  • Fibrous tissue forms at interface instead of bone with excessive motion
  • Micromotion less than 20-50 micrometers allows direct bone apposition
  • Primary stability at surgery critical for secondary biological fixation
Clinical Implication: Establishes 150 micrometer threshold for micromotion. Surgical technique must achieve rigid press-fit to prevent early micromotion and fibrous tissue formation.

Porous Coatings for Bone Ingrowth

4
Bobyn JD, et al. • J Bone Joint Surg Am (1980)
Key Findings:
  • Pore size 50-400 micrometers allows bone ingrowth
  • Optimal pore size 100-200 micrometers for maximal ingrowth
  • 30-50% porosity optimal (too dense prevents ingrowth, too porous weakens coating)
  • Interconnected pores required for bone penetration and vascularity
Clinical Implication: Defines design parameters for porous coatings. Modern acetabular cups and femoral stems use sintered beads or fiber metal with 100-200 micrometer pores and 30-50% porosity.

MCQ Practice Points

Exam Pearl

Q: What is the definition of osseointegration as described by Brånemark?

A: "Direct structural and functional connection between living bone and the surface of a load-bearing implant." Key features: no fibrous tissue interposition, bone-implant contact, and functional load transfer. Histologically defined as direct bone-to-implant contact without intervening soft tissue. Contrast with fibrous integration (fibrous capsule around implant = failure).

Exam Pearl

Q: What surface modifications improve osseointegration of titanium implants?

A: (1) Macro-texture: porous coating, plasma spray, sintered beads (allows bone ingrowth). (2) Micro-texture: grit-blasting, acid-etching (increases surface area). (3) Nano-texture: hydroxyapatite coating (osteoconductive, accelerates osseointegration). Rougher surfaces (Ra 1-2 μm) have better bone-implant contact than smooth surfaces. Hydroxyapatite coating accelerates initial osseointegration but may delaminate long-term.

Exam Pearl

Q: What is the optimal initial stability (primary fixation) for cementless implants to achieve osseointegration?

A: Micromotion under 150 μm (ideally under 50 μm). Micromotion greater than 150 μm leads to fibrous tissue formation instead of bone ingrowth. Press-fit interference (typically 1-2mm larger than prepared cavity) creates initial stability. Bone ingrowth occurs over 6-12 weeks. Early full weight-bearing may be permitted if press-fit is adequate.

Exam Pearl

Q: How does osseointegration differ between cemented and cementless implant fixation?

A: Cemented: PMMA cement fills gap between implant and bone; no direct bone-implant contact; relies on mechanical interlock (cement-bone and cement-implant interfaces). Cementless: Requires direct bone growth onto/into implant surface; no intermediate material; relies on biological fixation through bone ingrowth/ongrowth. Both can achieve excellent long-term fixation.

Exam Pearl

Q: What factors impair osseointegration of cementless implants?

A: (1) Excessive micromotion (greater than 150 μm), (2) Inadequate initial stability (poor press-fit), (3) Gap greater than 2mm between implant and bone, (4) Infection, (5) Patient factors: smoking, diabetes, bisphosphonates (controversial), radiation. NSAIDs may impair early bone healing but effect on osseointegration is controversial. Hydroxyapatite coating can bridge gaps up to 2mm.

Australian Context

AOANJRR and Osseointegration

Australian Orthopaedic Association National Joint Replacement Registry:

Cementless THA trends:

  • Cementless: 72% of primary THA (increasing)
  • Cemented: 7% (declining)
  • Hybrid (cementless cup, cemented stem): 21%

Key findings:

  • Cementless superior in patients under 65
  • Both excellent in 65-75 age group
  • Cemented may be preferred over 75

AOANJRR tracks:

  • Revision rates by fixation type
  • Individual prosthesis performance
  • Early identification of outliers

Australian Practice Patterns

Current trends in Australian arthroplasty:

THA:

  • Cementless fixation dominant
  • Titanium stems with porous coating standard
  • HA coating less common than porous titanium
  • Ceramic-on-XLPE most common bearing

TKA:

  • Cemented fixation remains standard (over 85%)
  • Cementless growing slowly
  • Trabecular metal cones for revision

Bone-anchored prostheses:

  • Available at select centers (Queensland, Victoria)
  • OPRA and ILP systems used
  • Strict selection criteria

AOANJRR Utility

The AOANJRR is one of the world's largest joint registries and provides invaluable real-world outcome data on osseointegration. It tracks revision rates by fixation method, surface type, and specific prosthesis brand. This allows early identification of poorly performing implants and informs evidence-based practice. In FRACS examinations, referencing AOANJRR data demonstrates knowledge of Australian evidence-based practice.

AOANJRR Detailed Data

Cumulative percent revision by fixation (THA 2023):

Cementless fixation:

  • 1 year: 0.9%
  • 5 years: 2.5%
  • 10 years: 4.0%
  • 15 years: 5.8%

Cemented fixation:

  • 1 year: 1.1%
  • 5 years: 2.4%
  • 10 years: 4.2%
  • 15 years: 6.4%

Hybrid:

  • Similar to cementless at most time points
  • Cementless cup shows excellent long-term integration

Australian Osseointegrated Prosthesis Program

Bone-anchored prosthetic limb in Australia:

Available centers:

  • Princess Alexandra Hospital (Brisbane)
  • St Vincent's Hospital (Melbourne)
  • Royal Melbourne Hospital

Systems used:

  • OPRA (Integrum)
  • ILP (Eska)

Australian outcomes:

  • 90-95% implant survival at 5 years
  • High patient satisfaction
  • Improved mobility vs socket prosthesis
  • Infection remains ongoing challenge

Funding:

  • NDIS coverage available for appropriate candidates
  • Strict selection criteria applied

TGA and Implant Regulation

Therapeutic Goods Administration considerations:

Implant registration:

  • All orthopaedic implants require TGA registration
  • Porous-coated implants from major manufacturers approved
  • Novel surface technologies require specific approval

Reporting requirements:

  • Adverse events reported to TGA
  • AOANJRR data contributes to safety monitoring
  • Surgeons responsible for informed consent

Recall history:

  • No major recalls of cementless surface technologies
  • HA coating issues identified through registry data
  • Continuous monitoring of implant performance

Sentinel Event System

The AOANJRR uses funnel plots to identify outlier implants. If a prosthesis has a revision rate outside the 99.8% control limit, it triggers a sentinel event - alerting the manufacturer, TGA, and surgeons. This early warning system allows rapid identification of failing implants before widespread harm occurs. It has been used to identify problems with metal-on-metal bearings and specific stem designs.

Exam Viva Scenarios

Practice these scenarios to excel in your viva examination

VIVA SCENARIOStandard

Viva Scenario: Ultrastructure of Osseointegration

EXAMINER

"An examiner asks you to describe what happens at the bone-implant interface at the molecular level during successful osseointegration."

EXCEPTIONAL ANSWER
Osseointegration begins when the titanium oxide layer (TiO₂, 2-10 nm thick) contacts blood and tissue proteins. Within seconds, proteins like **fibronectin and vitronectin** adsorb to the oxide surface. Osteoblast integrins recognize these proteins, allowing cell adhesion and spreading. Over days to weeks, osteoblasts deposit **osteoid matrix** directly on the protein-coated implant surface. This mineralizes to form woven bone in direct contact with the oxide layer - there is no intervening fibrous tissue. The ultrastructural gap between mineralized bone and oxide is less than 50 nm. Over months, this woven bone remodels to lamellar bone adapted to local stresses.
KEY POINTS TO SCORE
TiO₂ oxide layer (2-10 nm) is the bioactive surface, not titanium metal
Protein adsorption (fibronectin, vitronectin) mediates cell attachment
Osteoblast integrins bind to adsorbed proteins
Bone forms directly on implant surface (no fibrous tissue)
Ultrastructural gap less than 50 nm between bone mineral and oxide layer
COMMON TRAPS
✗Saying bone bonds to titanium (it bonds to the oxide layer)
✗Forgetting the role of adsorbed proteins in cell attachment
✗Not knowing the thickness of the oxide layer (2-10 nm)
✗Confusing osseointegration with fibrous encapsulation
VIVA SCENARIOStandard

Viva Scenario: Optimal Surface for Osseointegration

EXAMINER

"What surface characteristics optimize osseointegration in cementless total hip arthroplasty?"

EXCEPTIONAL ANSWER
The optimal surface for cementless THA osseointegration has **moderate-to-rough surface roughness (Ra 1-10 μm)** achieved by grit-blasting, acid-etching, or plasma spray. This provides an osteoconductive surface for contact osteogenesis. Additionally, **porous coatings** with pore size **50-400 μm** allow bone ingrowth and mechanical interlock. The surface should be biocompatible (titanium or titanium alloy with intact TiO₂ layer). Hydroxyapatite coating may accelerate early integration but has concerns about long-term coating integrity. Primary mechanical stability (press-fit) is essential to limit micromotion below 150 μm during healing. Modern cementless femoral stems achieve greater than 95% survival at 20 years with these surface characteristics.
KEY POINTS TO SCORE
Surface roughness Ra 1-10 μm (moderately rough) is optimal
Porous coating with 50-400 μm pores allows bone ingrowth
Titanium with intact TiO₂ layer for biocompatibility
Primary stability essential (micromotion less than 150 μm)
Hydroxyapatite accelerates early integration but may degrade
COMMON TRAPS
✗Recommending smooth surfaces (poor osseointegration)
✗Ignoring the importance of primary mechanical stability
✗Forgetting pore size requirements for bone ingrowth (50-400 μm)
✗Not mentioning micromotion threshold (150 μm)
VIVA SCENARIOStandard

Viva Scenario: Assessing Implant Osseointegration

EXAMINER

"A 65-year-old patient is 5 years post-cementless THA and presents with thigh pain. X-rays show a radiolucent line at the bone-implant interface. How do you assess whether the implant is osseointegrated or loose?"

EXCEPTIONAL ANSWER
I would assess osseointegration status through: (1) **Clinical history** - activity-related pain and start-up pain suggest loosening; (2) **Serial radiographs** - compare to immediate post-op and prior follow-ups to determine if radiolucent lines are progressive (key finding for loosening); (3) **Radiolucent line characteristics** - width (greater than 2mm = definite loosening), number of Gruen zones involved (complete = loose), and progression over time; (4) **Advanced imaging** - CT with MARS if plain films equivocal, to better characterize bone-implant interface and detect osteolysis; (5) **Nuclear medicine** - triple-phase bone scan if infection suspected, or labeled WBC scan. Progressive radiolucent lines in all zones with thigh pain and start-up symptoms indicate failure of osseointegration.
KEY POINTS TO SCORE
Progressive radiolucent lines are key indicator of loosening
Greater than 2mm lucency = definite failure of osseointegration
Complete zone involvement (all Gruen zones) = loose
Thigh pain and start-up pain are classic symptoms of femoral loosening
Compare to prior X-rays to determine progression
COMMON TRAPS
✗Diagnosing loosening based on single X-ray (need serial comparison)
✗Ignoring clinical symptoms (radiolucent lines need clinical correlation)
✗Forgetting to exclude infection as cause of loosening
✗Not knowing Gruen zone system for systematic reporting
VIVA SCENARIOStandard

Viva Scenario: Optimizing Osseointegration in THA

EXAMINER

"A 55-year-old diabetic smoker with osteoporosis requires primary THA. How do you optimize osseointegration in this high-risk patient?"

EXCEPTIONAL ANSWER
This patient has multiple risk factors for osseointegration failure. Optimization strategy: **Preoperative:** (1) Smoking cessation at least 4-6 weeks before surgery; (2) Optimize HbA1c to less than 7.5% if possible; (3) Address osteoporosis - bisphosphonates do NOT impair osseointegration and may help. **Intraoperative:** (4) Use porous-coated titanium stem with proven track record; (5) Ensure meticulous surgical technique with good press-fit; (6) Consider HA-coated implant to accelerate early integration. **Postoperative:** (7) Protected weight-bearing for 6-12 weeks given osteoporosis; (8) Strict glucose control; (9) Close radiographic follow-up for signs of loosening. If primary stability cannot be achieved intraoperatively, I would consider converting to cemented fixation.
KEY POINTS TO SCORE
Smoking cessation 4-6 weeks before surgery
HbA1c optimization (less than 7.5% ideal)
Bisphosphonates do NOT impair osseointegration
Porous titanium surface with good press-fit
Protected weight-bearing if primary stability suboptimal
Consider cemented fixation if press-fit not achievable
COMMON TRAPS
✗Stopping bisphosphonates (they do not impair integration)
✗Allowing immediate full weight-bearing in high-risk patient
✗Ignoring modifiable risk factors preoperatively
✗Persisting with cementless when press-fit not achieved
VIVA SCENARIOStandard

Viva Scenario: Intraoperative Decision-Making

EXAMINER

"During cementless THA, you insert the final broach but it feels slightly loose with some toggle. What do you do?"

EXCEPTIONAL ANSWER
If the final broach is loose with toggle, I have several options: (1) **Upsize the broach** by 1 size to achieve better press-fit - this is my first choice if bone stock permits; (2) **Use a longer stem** to engage more diaphyseal cortex if proximal bone is deficient; (3) If still unstable, consider **converting to cemented fixation** rather than accepting a loose cementless stem that will fail to osseointegrate. The key principle is that **primary stability is essential** - micromotion greater than 150 μm will result in fibrous encapsulation rather than osseointegration. I would not accept a loose cementless implant as it is destined to fail.
KEY POINTS TO SCORE
Upsize broach/stem to achieve press-fit
Consider longer stem for more diaphyseal engagement
Convert to cemented if press-fit cannot be achieved
Never accept a loose cementless implant
Primary stability is essential for osseointegration
COMMON TRAPS
✗Accepting a loose cementless stem (will fail)
✗Using cement around a loose cementless stem (poor technique)
✗Ignoring intraoperative signs of poor fixation
✗Not having backup cemented implants available
VIVA SCENARIOStandard

Viva Scenario: Aseptic Loosening

EXAMINER

"A patient is 8 years post-cementless THA with progressive thigh pain. X-rays show radiolucent lines in all Gruen zones and proximal femoral osteolysis. What is your diagnosis and management?"

EXCEPTIONAL ANSWER
This patient has **aseptic loosening with osteolysis** - failure of osseointegration. Key findings: progressive radiolucent lines in all zones indicate complete loosening; proximal osteolysis suggests wear debris-related bone destruction. Management: (1) **Confirm aseptic** - rule out infection with aspiration, inflammatory markers; (2) **Preoperative planning** - assess bone stock, plan for bone loss management; (3) **Revision THA** with: (a) removal of loose stem, (b) debridement of fibrous tissue and osteolytic lesions, (c) bone grafting if needed, (d) new cementless stem with porous coating achieving press-fit in remaining bone, or cemented stem if bone quality poor; (4) Address bearing surface - use XLPE to reduce future wear.
KEY POINTS TO SCORE
Progressive radiolucent lines in all zones = definite loosening
Rule out infection before revision (aspiration, CRP/ESR)
Assess bone stock for revision planning
Address osteolysis with debridement and bone grafting
Use low-wear bearing (XLPE) to prevent recurrence
COMMON TRAPS
✗Proceeding to revision without ruling out infection
✗Ignoring osteolytic lesions (will progress if not addressed)
✗Using conventional PE (will cause recurrent osteolysis)
✗Not having backup plan for severe bone loss
VIVA SCENARIOStandard

Viva Scenario: Postoperative Pain

EXAMINER

"A patient is 6 months post-cementless THA and reports mild thigh pain with weight-bearing. X-rays show stable implant position with no radiolucent lines. How do you manage this?"

EXCEPTIONAL ANSWER
Mild thigh pain at 6 months post-cementless THA is concerning but may represent normal healing or early loosening. Management: (1) **Characterize the pain** - start-up pain suggests loosening; activity-related pain may be normal muscle recovery; (2) **Compare X-rays** to immediate postop - any change in position or new lucencies?; (3) **Physical exam** - hip ROM, tenderness, gait; (4) **Observe** if X-rays stable and symptoms mild - repeat X-ray in 3 months to confirm no progression; (5) **Advanced imaging** if symptoms persist or worsen - CT with MARS, bone scan; (6) **Rule out infection** if any concern - ESR, CRP, aspiration. Most mild thigh pain after cementless THA resolves by 12-18 months as bone remodeling completes.
KEY POINTS TO SCORE
Mild thigh pain can be normal up to 12-18 months post-cementless THA
Compare all X-rays to baseline for accurate assessment
Start-up pain is more concerning than activity-related pain
Serial X-rays to confirm no progression
Advanced imaging if symptoms persist or worsen
COMMON TRAPS
✗Ignoring thigh pain (could be early loosening)
✗Overreacting to mild symptoms with normal X-rays
✗Not having baseline X-rays for comparison
✗Forgetting to consider infection as a cause
VIVA SCENARIOStandard

Viva Scenario: Cemented vs Cementless Decision

EXAMINER

"A 72-year-old patient with moderate osteoporosis requires primary THA. Would you use cemented or cementless fixation?"

EXCEPTIONAL ANSWER
For this 72-year-old with osteoporosis, I would consider both options carefully. **For cementless:** Modern cementless stems with excellent track records can achieve good osseointegration even in moderate osteoporosis if I can achieve adequate press-fit intraoperatively. AOANJRR shows similar outcomes up to age 75. **For cemented:** Provides immediate stability regardless of bone quality, no reliance on osseointegration, may be advantageous in osteoporotic bone. **My approach:** I would attempt cementless if I can achieve good press-fit intraoperatively (stable broach with no toggle). If I cannot achieve adequate primary stability due to osteoporosis, I would convert to cemented fixation. I would have both options available in the operating room.
KEY POINTS TO SCORE
Both cemented and cementless can work in this patient
Intraoperative assessment of press-fit guides decision
Have backup cemented implants available
AOANJRR shows good outcomes for both up to age 75
Severe osteoporosis may favor cemented fixation
COMMON TRAPS
✗Dogmatically choosing one option without considering alternatives
✗Accepting poor press-fit with cementless in osteoporotic bone
✗Not having backup cemented implants available
✗Ignoring patient-specific factors
VIVA SCENARIOStandard

Viva Scenario: Using Registry Data

EXAMINER

"An examiner asks you how the AOANJRR helps monitor osseointegration outcomes in Australia."

EXCEPTIONAL ANSWER
The AOANJRR monitors osseointegration through several mechanisms: (1) **Revision rate tracking** by fixation type (cemented vs cementless) allows comparison of biological vs mechanical fixation outcomes; (2) **Individual prosthesis analysis** identifies specific implant designs with higher-than-expected failure rates (outliers); (3) **Age-stratified data** informs appropriate patient selection for cementless fixation; (4) **Funnel plots** statistically identify outlier prostheses with 99.8% control limits triggering sentinel events; (5) **Surgeon feedback** allows individual surgeons to benchmark their outcomes. The registry has over 1.5 million procedures recorded, providing robust long-term data on osseointegration success across different surface technologies and patient populations.
KEY POINTS TO SCORE
AOANJRR tracks revision rates by fixation type
Individual prosthesis performance monitoring
Funnel plots identify statistical outliers
Age-stratified data guides patient selection
Surgeon-level feedback available
COMMON TRAPS
✗Not knowing AOANJRR exists or its significance
✗Confusing registry data with RCT data
✗Not mentioning sentinel event system
✗Failing to reference Australian data in viva

OSSEOINTEGRATION

High-Yield Exam Summary

Core Definition and History

  • •Direct bone-implant contact without fibrous tissue layer
  • •Brånemark 1952 discovery (titanium in rabbit bone), coined term 1981
  • •First applied to dental implants, then orthopaedic surgery
  • •Titanium gold standard due to TiO2 oxide layer (2-10 nm, biocompatible)

Requirements for Success

  • •Biocompatible material: Titanium, tantalum, hydroxyapatite
  • •Primary stability: Micromotion LESS than 150 micrometers (critical threshold)
  • •Gap distance: Less than 500 micrometers (ideally less than 200 micrometers)
  • •Surface roughness: Ra 1-10 micrometers optimal (moderate roughness)
  • •Protected loading: 6-12 weeks weight-bearing restriction
  • •Adequate bone quality, vascularity, no infection

Biological Mechanisms

  • •Contact osteogenesis: Bone forms ON implant surface (rough surface required)
  • •Distance osteogenesis: Bone grows FROM host bed across gap (less than 500 micrometers)
  • •Timeline: Week 2-4 woven bone, Week 4-12 remodeling, Month 3-6 mature lamellar
  • •Bone-implant contact: 60-90% in successful integration

Primary vs Secondary Stability

  • •Primary = mechanical press-fit at surgery (friction, geometry)
  • •Secondary = biological fixation via bone formation (3-6 months)
  • •Stability valley at 6-8 weeks (primary declining, secondary developing)
  • •This is most critical period - protected weight-bearing essential
  • •Excessive micromotion during this period → fibrous tissue → failure

Surface Modifications

  • •Grit-blast + acid-etch: Creates Ra 1-5 micrometers (standard)
  • •Porous coatings: 100-200 micrometer pores, 30-50% porosity (bone ingrowth)
  • •Hydroxyapatite coating: Accelerates early integration but may resorb
  • •Smooth surface (Ra less than 0.5 micrometers): Poor integration, fibrous tissue

Critical Numbers

  • •Micromotion threshold: Less than 150 micrometers (above = fibrous tissue)
  • •Gap limit: Less than 500 micrometers for integration
  • •Optimal roughness: Ra 1-10 micrometers
  • •Optimal pore size: 100-200 micrometers for ingrowth
  • •Integration timeline: 3-6 months for mature lamellar bone
  • •Protected weight-bearing: 6-12 weeks minimum

Clinical Applications

  • •Cementless THA/TKA: Porous-coated stems and cups
  • •Dental implants: Original Brånemark application
  • •Spinal implants: Pedicle screws, titanium cages (not PEEK)
  • •Bone-anchored prostheses: Transcutaneous implants for limb loss
  • •Indications: Young patients, good bone quality vs cemented in elderly/osteoporotic

Exam Tips and Traps

  • •Always mention Brånemark when defining osseointegration
  • •Know micromotion threshold (150 micrometers) - frequently asked
  • •Explain stability valley concept (6-8 weeks critical)
  • •Titanium oxide layer (TiO2) essential for biocompatibility
  • •PEEK does NOT osseointegrate (bioinert, not bioactive)
  • •HA coating accelerates early but no long-term advantage proven
Quick Stats
Reading Time222 min
Related Topics

Titanium Alloys

Bioabsorbable Materials

Cobalt Chrome Alloys

Biofilm Formation in Orthopaedic Infections